By Fineline Cube 
Peijia Medical Ltd (HKG: 9996) announced that it has received market approval from China’s National Medical Products Administration (NMPA) for its YonFlow blood flow-guided dense mesh stent. This approval marks a significant milestone in the company’s vascular intervention portfolio.
Product Innovation
The YonFlow stent, developed by NowYon Medical, is described as the world’s first fully releasable and recyclable dense mesh stent system. It offers precise control during surgical procedures and is designed to enhance treatment outcomes for vascular diseases.
Material and Design
Made from a cobalt-chromium alloy, the stent provides robust radial support and excellent vascular wall adhesion. These features position YonFlow as a superior solution for precise vascular interventions.
Market Potential
Peijia Medical secured marketing and distribution rights for YonFlow in Greater China through a licensing agreement with NowYon Medical in August 2024. This strategic move expands Peijia’s presence in the vascular medical device market and underscores its commitment to innovative solutions.-Fineline Info & Tech